Dld Asset Management, LP Biocryst Pharmaceuticals Inc Put Options Transaction History

Dld Asset Management, LP

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $1.05 Million - $3.29 Million	-359,600 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.38 - $9.72 $2.65 Million - $3.5 Million	359,600 New	359,600 $2.93 Million

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.